Upholding a High View of Science and a High View of Scripture
Dr. Ross Anderson
M.B.S. in Molecular, Cellular, and Developmental Biology, PhD in Biochemistry, Full Professor of Biochemistry, Logos Research Associate
Dr. Anderson was a Robert A. Welch pre-doctoral fellow in chemistry. He received his Ph.D. in Biochemistry from Baylor College of Medicine, Houston, TX. He then became an NIH post-doctoral fellow and did work in the Molecular Genetics Division of the Department of Ophthalmology at the Houston Neurosensory Center. There he worked on aspects of light transduction in the retina of the eye. Dr. Anderson has taught Biochemistry to medical and graduate students at Baylor College of Medicine and directed research activities of many of these same students. He later became a member of both the undergraduate and graduate faculty in the Department of Biology at Lamar University, Beaumont, TX. There he taught and directed the research of students working toward a Masters Degree in Biology.
Dr. Anderson’s research interests are in the areas of cellular and sub-cellular biology and physiology. He currently works on the synthesis and expression of synthetic genes coding for human DNA polymerases for the purpose of protein structure-function studies. Dr. Anderson has authored or co-authored several research publications in major, peer-reviewed journals. He is a member of the Sigma Xi Biological Research Society and the American Chemical Society.
Dr. Anderson is currently a full professor in the Department of Biological and Physical Sciences at The Master’s University, Santa Clarita, CA where he has been for the past twenty years.
1971 - 1974 Member Beta Beta Beta National Honorary Biological Society, Austin College.
1984 Dean’s List in Chemistry, University of Houston.
1986 - 1987 Robert A. Welch Predoctoral Fellow in Biochemistry, Baylor College of Medicine.
1997 - 1998 Nominated Outstanding Faculty Member of the Year, Lamar University, Baumont, TX.
1994-1996 NEI/NIH National Research Service Award, EY06487, “Isolation and Characterization of Retinal Phospholipase C’s”.
1996-1997 Texas Research Enhancement Award, no. 210236, through Lamar University to carry out research on synthetic genes.
1996-1998 Research contract with Supertechs, Bethesda, MD. To perform structure/function studies on Terminal Deoxynucleotidyltransferase.
1997-1998 Sigma Xi/National Academy of Sciences Research Grants-in-Aid Award, no. NAS- July97, to do research on Retinal Guanylyl Cyclase Activating Proteins.
1. Anderson, R. S., Lawrence, C. B., Wilson, S. H., and Beattie, K. L. (1987) “Genetic relatedness of human DNA polymerase b and terminal deoxynucleotidyltransferase.” Gene, 60:163 - 173.
2. Beattie, K. L., Logsdon, N. J., Anderson, R. S., Espinosa-Lara, J. M., Maldonado-Rodriguez, R., and Frost, J. D.,III, (1988) “Gene synthesis technology: Recent Developments and Future Prospects.” Review, Biotechnology and Applied Biochemistry, 10:510-521.
3. Bonilla, F. A., Anderson, R. S., Atassi, M. Z., and Bona, C. A. (1989) “A VH region synthetic peptide induces antibodies which bind native immunoglobins and augment an immune response to antigen” Adv. Exptl. Med. Biol., 251:129-144.
4. Ling, Y.-H., Nelson, J. A., Cheng, Y-C., Anderson, R. S., and Beattie, K. L. (1992) “2-Deoxy-6-thioguanosine 5’-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.” Molecular Pharmacology, 40:508-514.
5. Kirk, E. E., Giordano, J., and Anderson, R. S. (1997) “Serotonergic Receptors as Targets for Pharmacotherapy: A Brief Review.” J. Neuroscience Nursing 29:191-197.
6. Anderson, Ross S., Bollum, Fred J., and Beattie, Kenneth L. (1999) “Pyrophosphorolytic Dismutation of Oligonucleotides by Terminal Deoxynucleotidyltransferase.” Nucleic Acids Research 27: 3190-3196.